X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2419) 2419
Book Review (372) 372
Publication (129) 129
Magazine Article (103) 103
Dissertation (37) 37
Conference Proceeding (20) 20
Book Chapter (14) 14
Book / eBook (7) 7
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (890) 890
humans (697) 697
cholesterol (513) 513
subtilisin/kexin type 9 (464) 464
hypercholesterolemia (339) 339
kexin (332) 332
可信 (331) 331
pcsk9 (315) 315
subtilisin (303) 303
male (295) 295
statins (295) 295
lipids (290) 290
monoclonal-antibody (285) 285
proprotein convertase 9 (282) 282
proprotein convertase subtilisin/kexin type 9 (278) 278
low density lipoproteins (275) 275
animals (272) 272
lipoproteins (272) 272
cardiac & cardiovascular systems (262) 262
atherosclerosis (259) 259
familial hypercholesterolemia (253) 253
female (245) 245
cardiovascular disease (233) 233
density-lipoprotein cholesterol (230) 230
heterozygous familial hypercholesterolemia (223) 223
cholesterol, ldl - blood (216) 216
biochemistry & molecular biology (213) 213
pharmacology & pharmacy (192) 192
low density lipoprotein (191) 191
middle aged (187) 187
cardiovascular diseases (178) 178
coronary-heart-disease (173) 173
ldl cholesterol (173) 173
risk factors (171) 171
proprotein convertase subtilisin (160) 160
kexin type 9 (159) 159
mice (154) 154
peripheral vascular disease (154) 154
double-blind (152) 152
monoclonal antibodies (147) 147
hypercholesterolemia - drug therapy (139) 139
proprotein convertase 9 - antagonists & inhibitors (132) 132
serine endopeptidases - metabolism (132) 132
anticholesteremic agents - therapeutic use (131) 131
metabolism (126) 126
safety (124) 124
antibodies, monoclonal - therapeutic use (123) 123
serine endopeptidases - genetics (122) 122
mutation (120) 120
可信计算 (120) 120
aged (119) 119
efficacy (118) 118
receptors, ldl - metabolism (118) 118
research (118) 118
ldl receptor (114) 114
autosomal-dominant hypercholesterolemia (113) 113
analysis (112) 112
endocrinology & metabolism (111) 111
adult (110) 110
alirocumab (109) 109
treatment outcome (109) 109
evolocumab (107) 107
placebo-controlled trial (105) 105
risk (105) 105
proprotein convertases - antagonists & inhibitors (104) 104
proteins (104) 104
proprotein convertase 9 - metabolism (103) 103
proprotein convertases - metabolism (103) 103
ldl-cholesterol (102) 102
clinical trials (101) 101
statin therapy (101) 101
reducing lipids (100) 100
cardiovascular (98) 98
patients (98) 98
dyslipidemia (97) 97
care and treatment (96) 96
genetic aspects (94) 94
lipid metabolism (93) 93
low-density lipoprotein cholesterol (93) 93
proprotein convertases (92) 92
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (90) 90
liver (90) 90
density-lipoprotein receptor (89) 89
low-density-lipoprotein (88) 88
cardiology (87) 87
ldl (87) 87
cardiovascular-disease (86) 86
abridged index medicus (85) 85
expression (85) 85
ezetimibe (84) 84
health aspects (82) 82
medicine, general & internal (82) 82
apolipoproteins (81) 81
diabetes (81) 81
drug therapy (81) 81
medicine & public health (81) 81
triglycerides (81) 81
cardiovascular events (80) 80
ldl-c (80) 80
evolocumab amg 145 (79) 79
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1289) 1289
Chinese (1243) 1243
German (25) 25
Spanish (10) 10
Russian (5) 5
French (3) 3
Hungarian (2) 2
Italian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, The new Hong Kong cinema series, ISBN 9789622099708, xiv, 147
This raucous, gender-stretching comedy follows the disruptions of a glamorous Hong Kong music couple's tumultuous romance by an "ordinary" fan's noisy arrival... 
Chen, Kexin, 1962- He's a woman, she's a man | Motion pictures | Performing Arts | Film Studies/Asian Studies/Cultural Studies | Film, Media and Mass Communication | Anthropology | 20th century | 1962 | He's a woman, she's a man | Chen, Kexin
Book
Journal of Lipid Research, ISSN 0022-2275, 2018, Volume 59, Issue 2, pp. 207 - 223
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 11/2014, Volume 55, Issue 11, pp. 2370 - 2379
LDL cholesterol (LDL-C) contributes to coronary heart disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9) increases LDL-C by inhibiting LDL-C... 
Anti-proprotein convertase subtilisin/kexin type 9 antibody | Proprotein convertase subtilisin/kexin type 9 | Low density lipoprotein receptor | Apolipoprotein E | proprotein convertase subtilisin/kexin type 9 | FAMILIAL HYPERCHOLESTEROLEMIA | ESTER TRANSFER PROTEIN | AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA | BIOCHEMISTRY & MOLECULAR BIOLOGY | SUBTILISIN/KEXIN TYPE 9 | anti-proprotein convertase subtilisin/kexin type 9 antibody | low density lipoprotein receptor | MONOCLONAL-ANTIBODY | KNOCKOUT MICE LACKING | REDUCES ATHEROSCLEROSIS | LOWERING PLASMA-CHOLESTEROL | apolipoprotein E | DENSITY-LIPOPROTEIN RECEPTOR | TRANSGENIC MICE | Apolipoproteins E - deficiency | Atherosclerosis - genetics | Cholesterol - blood | Humans | Proprotein Convertases - genetics | Atherosclerosis - enzymology | Liver - drug effects | Serine Endopeptidases - genetics | Serine Endopeptidases - immunology | Antibodies - immunology | Female | Serine Endopeptidases - deficiency | Liver - metabolism | Proprotein Convertases - metabolism | Receptors, LDL - metabolism | Gene Knockout Techniques | Proprotein Convertases - deficiency | Atherosclerosis - metabolism | Proprotein Convertases - immunology | Atherosclerosis - blood | Animals | Mice | Serine Endopeptidases - metabolism | Cholesterol Ester Transfer Proteins - metabolism | Proprotein Convertase 9 | Index Medicus | kexin type 9 antibody | kexin type 9 | proprotein convertase subtilisin | anti-proprotein convertase subtilisin
Journal Article
2006, ISBN 9781402047930, x, 157
Convertases are widely expressed activating enzymes involved in various physiological and pathological processes. This book provides detailed and updated... 
Enzyme inhibitors | Treatment | Genetic aspects | Carcinogenesis | Molecular aspects | Therapeutic use | Cancer | Cancer Research | Oncology | Biomedicine | Chemistry/Food Science, general
Book
Journal Article
Circulation. Cardiovascular Genetics, ISSN 1942-325X, 07/2018, Volume 11, Issue 7, pp. e002247 - e002247
Journal Article
Biochemical Journal, ISSN 0264-6021, 05/2009, Volume 419, Issue 3, pp. 577 - 584
PCSK9 (proprotein convertase subtilisin/kexin type 9) promotes degradation of the LDLR [LDL (low-density lipoprotein) receptor] through an as-yet-undefined... 
Surface plasmon resonance | Protein-protein interaction | Low-density lipoprotein receptor | Proprotein convertase subtilisin/kexin type 9 (PCSK9) | Antibody-mediated disruption | Cholesterol | FAMILIAL HYPERCHOLESTEROLEMIA | low-density lipoprotein receptor | LDL RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | antibody-mediated disruption | SECRETED PCSK9 | MUTANTS | PLASMA-CHOLESTEROL | GENE | surface plasmon resonance | cholesterol | DEGRADATION | protein-protein interaction | MICE | MUTATIONS | EXPRESSION | proprotein convertase subtilisin/kexin type 9 (PCSK9) | Cell Line | Reproducibility of Results | Humans | Insecta | Extracellular Space - drug effects | Models, Molecular | Receptors, LDL - metabolism | Mutant Proteins - metabolism | Epitopes | Antibodies - pharmacology | Extracellular Space - metabolism | Animals | Protein Binding - drug effects | Cholesterol, LDL - metabolism | Serine Endopeptidases - metabolism | Kinetics | Proprotein Convertases | Serine Endopeptidases - isolation & purification | Proprotein Convertase 9 | Index Medicus | kexin type 9 | proprotein convertase subtilisin | BODIPY®, boron dipyrromethene (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | LDLc, LDL-cholesterol | FBS, fetal bovine serum | protein–protein interaction | kexin type 9 (PCSK9) | LDLR, LDL receptor | CHRD, cysteine | histidine-rich domain | MOI, multiplicity of infection | PCSK9, proprotein convertase subtilisin | RU, resonance units | HEK-F cells, Freestyle™ suspension human embryonic kidney cells | aa, amino acids | EGF-A, epidermal growth factor-like repeat A | LDL, low-density lipoprotein | SPR, surface plasmon resonance | IL1Ra, interleukin-1 receptor antagonist
Journal Article
Circulation. Cardiovascular Genetics, ISSN 1942-325X, 05/2018, Volume 11, Issue 5, pp. e002165 - e002165
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 70, Issue 17, pp. 2128 - 2136
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 2017, Volume 58, Issue 10, pp. 2008 - 2016
An elevated level of lipoprotein (a) [Lp(a)] is a risk factor for CVD. Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9, is... 
Drug therapy/hypolipid-emic drugs | Lipoproteins | Genetic variability | Apolipoprotein (a) | Hypercholesterolemic | Low density lipoprotein cholesterol reduction | Proprotein convertase subtilisin/kexin type 9 | Familial hypercholesterolemia | Monoclonal antibody | Apolipoproteins | Lipoprotein (a) | Clinical studies | proprotein convertase subtilisin/kexin type 9 | apolipoproteins | MYOCARDIAL-INFARCTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | hypercholesterolemic | PLASMA LIPOPROTEIN(A) | SUBTILISIN/KEXIN TYPE 9 | MONOCLONAL-ANTIBODY | drug therapy/hypolipidemic drugs | lipoprotein (a) | genetic variability | LDL CHOLESTEROL | DENSITY-LIPOPROTEIN CHOLESTEROL | CARDIOVASCULAR RISK-FACTOR | APOLIPOPROTEIN(A) ISOFORMS | familial hypercholesterolemia | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | PCSK9 INHIBITION | apolipoprotein (a) | clinical studies | monoclonal antibody | lipoproteins | low density lipoprotein cholesterol reduction | Gene Expression Regulation - drug effects | Protease Inhibitors - pharmacology | Phenotype | Protein Isoforms - metabolism | Proprotein Convertase 9 - antagonists & inhibitors | Protein Isoforms - chemistry | Antibodies, Monoclonal - pharmacology | Humans | Apoprotein(a) - metabolism | Apoprotein(a) - chemistry | Lipoproteins (low density) | Hypercholesterolemia | Kexin | Alleles | Clinical trials | Monoclonal antibodies | Dominance | Subtilisin | Gene polymorphism | Low density lipoprotein | Cholesterol | Index Medicus | kexin type 9 | drug therapy | proprotein convertase subtilisin | hypolipidemic drugs
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 16, pp. 1500 - 1509
Journal Article
Journal Article